107910-75-8|Ganciclovir Sodium|sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate|-范德生物科技公司

Ganciclovir Sodium

NMR下载 COA and HPLC MSDS下载
names：
sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate
CAS号：
107910-75-8
MDL Number：
MF(分子式)： C9H12N5NaO4 MW(分子量)： 277.21
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Ganciclovir Sodium
英文别名	Ganciclovir Sodium; RS-21592 sodium; Cytovene IV; RS 21592 Sodium; BIOLF-62; BW-759 sodium; Cytovene;
CAS号	107910-75-8
Inchi	InChI=1S/C9H13N5O4.Na/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16;/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17);/q;+1/p-1
InchiKey	JJICLMJFIKGAAU-UHFFFAOYSA-M
分子式 Formula	C9H12N5NaO4
分子量 Molecular Weight	277.21
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Ganciclovir Sodium(CAS:107910-75-8 ):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Ganciclovir Sodium is an acyclovir analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Mulye NV, Turco SJ, Speaker TJ. Stability of ganciclovir sodium in aninfusion-pump syringe. Am J Hosp Pharm. 1994 May 15;51(10):1348-9. PubMed PMID:8085576.

[2]Johnson CE, Jacobson PA, Chan E. Stability of ganciclovir sodium and aminoacids in parenteral nutrient solutions. Am J Hosp Pharm. 1994 Feb 15;51(4):503-8.PubMed PMID: 8017417.

[3] Phaypradith S, Vigneron J, Perrin A, Durney-Archeray MJ, Hoffman MA, HoffmanM. [Stability of dilute solutions of ganciclovir sodium (Cymevan) inpolypropylene syringes and PVC perfusion bags]. J Pharm Belg. 1992Nov-Dec;47(6):494-8. French. PubMed PMID: 1289490.

[4] Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA. Stability ofganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injectionover 35 days. Am J Hosp Pharm. 1992 Jan;49(1):116-8. PubMed PMID: 1570851.

[5] Silvestri AP, Mitrano FP, Baptista RJ, Williams DA. Stability andcompatibility of ganciclovir sodium in 5% dextrose injection over 35 days. Am JHosp Pharm. 1991 Dec;48(12):2641-3. PubMed PMID: 1814209.

6: Outman WR, Mitrano FP, Baptista RJ. Visual compatibility of ganciclovir sodiumand total parenteral nutrient solution during simulated Y-site injection. Am JHosp Pharm. 1991 Jul;48(7):1538-9. PubMed PMID: 1909095.7: Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA. Stability ofganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chlorideinjections. Am J Hosp Pharm. 1986 Nov;43(11):2810-2. PubMed PMID: 3492139.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开